These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 17569198)
1. Pneumococcal vaccination in adults: recommendations, trends, and prospects. Targonski PV; Poland GA Cleve Clin J Med; 2007 Jun; 74(6):401-6, 408-10, 413-4. PubMed ID: 17569198 [TBL] [Abstract][Full Text] [Related]
2. Preventing pneumococcal disease. ACIP recommends pneumococcal polysaccharide vaccine for all adults age > or = 65. Whitney CG Geriatrics; 2003 Oct; 58(10):20-2, 25. PubMed ID: 14569639 [TBL] [Abstract][Full Text] [Related]
3. Vaccine Update: Recommendation for conjugate pneumococcal and pneumococcal polysaccharide vaccines in adults older than 65 years. Niemi SA; Foster SL; Hayney MS J Am Pharm Assoc (2003); 2015; 55(2):212, 214-5. PubMed ID: 25749266 [No Abstract] [Full Text] [Related]
4. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Advisory Committee on Immunization Practices MMWR Recomm Rep; 2000 Oct; 49(RR-9):1-35. PubMed ID: 11055835 [TBL] [Abstract][Full Text] [Related]
5. Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe. Bonnave C; Mertens D; Peetermans W; Cobbaert K; Ghesquiere B; Deschodt M; Flamaing J Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):785-791. PubMed ID: 30778705 [TBL] [Abstract][Full Text] [Related]
6. Pneumococcal conjugate vaccine for young children. Selman S; Hayes D; Perin LA; Hayes WS Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663 [TBL] [Abstract][Full Text] [Related]
7. Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs. Grogg SE; Schultz J J Am Osteopath Assoc; 2015 Jun; 115(6 Suppl):S6-25. PubMed ID: 26000904 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors, mortality and pneumococcal vaccination recommendations in bacteriemica pneumococcal pneumonia]. Jover Díaz F; Andreu Giménez L; Roig Rico P; Cañizares Navarro R; Ortiz de La Tabla V; Cuadrado Pastor JM An Med Interna; 2003 May; 20(5):269-70. PubMed ID: 12831303 [No Abstract] [Full Text] [Related]
9. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination. Brotherton AL; Shah R R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563 [TBL] [Abstract][Full Text] [Related]
10. Pneumococcal vaccination of elderly adults: new paradigms for protection. Jackson LA; Janoff EN Clin Infect Dis; 2008 Nov; 47(10):1328-38. PubMed ID: 18844484 [TBL] [Abstract][Full Text] [Related]
11. Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age. Isturiz RE; Hall-Murray C; McLaughlin JM; Snow V; Schmoele-Thoma B; Webber C; Thompson A; Scott DA Expert Rev Vaccines; 2018 Jan; 17(1):45-55. PubMed ID: 29183235 [TBL] [Abstract][Full Text] [Related]
12. [Pneumococcal vaccine in adults: comparison of recommendations and discussion of its role]. Borsu K; Krammisch H; Franckh M; Giet D Rev Med Liege; 2010 Apr; 65(4):191-8. PubMed ID: 20499821 [TBL] [Abstract][Full Text] [Related]
13. New pneumococcal-vaccine recommendations include strategies for increasing vaccine use. Am J Health Syst Pharm; 1997 Aug; 54(15):1688. PubMed ID: 9262738 [No Abstract] [Full Text] [Related]
14. HHS-CDC news: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease--US, 1998-2003. Ann Pharmacother; 2005 Nov; 39(11):1967-8. PubMed ID: 16219891 [No Abstract] [Full Text] [Related]
15. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview. Vila-Corcoles A; Ochoa-Gondar O Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. Robinson KA; Baughman W; Rothrock G; Barrett NL; Pass M; Lexau C; Damaske B; Stefonek K; Barnes B; Patterson J; Zell ER; Schuchat A; Whitney CG; JAMA; 2001 Apr; 285(13):1729-35. PubMed ID: 11277827 [TBL] [Abstract][Full Text] [Related]
19. Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project. Bardenheier BH; Shefer A; McKibben L; Roberts H; Rhew D; Bratzler D J Am Med Dir Assoc; 2005; 6(5):291-9. PubMed ID: 16165069 [TBL] [Abstract][Full Text] [Related]
20. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). American Academy of Pediatrics Committee on Infectious Diseases Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]